Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Apr 2021 - Mar 2022
Lobbyists (Full time equivalent)
7.25 Fte (8)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
International Drug Policy Consortium (IDPC)
EU Transparency Register
75318797051-52 First registered on 01 Nov 2011
Goals / Remit
IDPC is a a global network of NGOs that come together to amplify and strengthen a diverse global movement to repair the harms caused by punitive drug policies, and promote just responses. Our advocacy positions are based on five core policy principles - drug policies should:
- be developed through an objective assessment of priorities and evidence
- comply with human rights principles, laws and standards
- focus on reducing the harmful consequences, rather than the scale, of drug use and markets
- promote social justice and the inclusion of marginalised groups
- meaningfully involve civil society and affected populations.
IDPC produces briefing papers, disseminates key resources on drug policy, builds the advocacy capacity of our members and partners, and offers expert advice to policy makers and officials around the world. Our global membership has expertise and experience on the wide spectrum of drug policy issues.Main EU files targeted
IDPC is part of the EU Civil Society Forum on Drugs (CSFD). As such, we engage directly in activities aimed at advising and providing recommendations to EU institutions around drug policy issues. IDPC's Research and Advocacy Officer is a member of the Core Group of the CSFD.
Individually, IDPC also collaborates with partners to organise seminars and discussions, as well as produce briefing papers and position papers on European drug policies. IDPC holds regular meetings with EU institutions, including the EMCDDA, Members of European Parliament, the HDG, the European Council, the European Commission (DG Home) and the EEAS.Address
Head Office
61 Mansell Street
London E1 8AN
UNITED KINGDOMEU Office
61 Mansell Street
London E1 8AN
UNITED KINGDOMWebsite
-
People
Total lobbyists declared
8
Employment time Lobbyists 100% 7 25% 1 Lobbyists (Full time equivalent)
7.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
IDPC staff includes seven full time staff members and one part time staff member. We also hire consultants around the world who work on thematic or regional issues related to drug policy. Three members of our staff are regularly in touch with EU institutions. For more information on the IDPC team, please visit: www.idpc.net/team.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
IDPC is a member of the European Civil Society Forum on Drugs, of the Vienna NGO Committee on Drugs, and of the New York NGO Committee on Drugs, as well as CoNGO. IDPC also has ECOSOC Consultative Status.
Member organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Apr 2021 - Mar 2022
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
1,788,000€
Major funding types in closed year
Grants, EU funding
Major contributions in closed year
Type Name Amount Contribution GIZ 105,064€ Contribution Open Society Foundations 155,000€ Contribution Robert Carr Fund 1,327,000€ Contribution VOICE 48,000€ Grant European Commission (via UNAD) 6,000€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
Commission expert group - Civil Society Forum on Drugs#E02681#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?groupID=2681 #Member #C#Civil society#Sub-group on Relations with International Institutions
Groups (European Parliament)
N/A
Other activities
For 3 years (2010-2014), under grants from the European Commission Drug Prevention and Information Programme, IDPC conducted a number of activities across Europe, in collaboration with key NGO partners.
In 2010-2011, IDPC supported the creation of a dynamic network of NGOs from South East Europe to promote exchange of information and experience among professionals in the field of drug policy in the region. We also produced a number of publications focused on South East Europe and Western European countries.
Between 2012 and 2014, IDPC was involved in a project funded by the European Commission in collaboration with the Transnational Institute and other European NGOs. This project aimed to promote exchange of experience through informal drug policy dialogues, expert seminars and the drafting of expert publications on issues related to the European Union and European countries.
Meetings
Meetings
None declared